Argos Reports Third Quarter 2017 Financial Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Argos Therapeutics (ARGS) Reports Q3 Loss of $0.10/Share
November 9, 2017 4:58 PM ESTArgos Therapeutics (NASDAQ: ARGS) reported Q3 EPS of ($0.10), versus ($0.32) reported last year. Revenue for the quarter came in at $53.5 thousand, versus $146.76 thousand reported last year.
For earnings history and earnings-related data on Argos Therapeutics (ARGS) click here.
... More